Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Fasting-mimicking diet changes gut microbiota to reduce IBD pathology in mice

Dietary modifications are frequently used to treat inflammatory bowel diseases.

6 Mar 2019

New mathematical method to map cell regulatory networks

Faster results. Lower costs. Fewer cells. A new mathematical method developed by researchers at Cincinnati Children's and New York University may soon make it much easier to conduct more of the complex data analysis needed to drive advances in the exploding field of personalized medicine.

6 Mar 2019

Daily cup of cocoa may reduce tiredness in multiple sclerosis

A new study has shown that drinking a cup of flavonoid-enriched cocoa each day could help to reduce fatigue in people suffering from multiple sclerosis.

5 Mar 2019

Sleep apnea may be related to higher accumulation of Alzheimer's biomarker in the brain

People who are witnessed by a bed partner to have stopped breathing during sleep may have higher accumulations of an Alzheimer's disease biomarker called tau in an area of the brain that helps with memory, according to a preliminary study released today that will be presented at the American Academy of Neurology's 71st Annual Meeting in Philadelphia, May 4 to 10, 2019.

4 Mar 2019

Research reveals how metabolites can be used to inhibit epigenetic mechanisms and treat MS

Understanding and mitigating the role of epigenetics (environmental influences that trigger changes in gene expression) in disease development is a major goal of researchers.

28 Feb 2019

National Multiple Sclerosis Society awards grant for pilot study of social interaction in individuals with MS

Ekaterina Dobryakova, PhD, and Pei-Pei Liu, PhD, were awarded a $50,000 grant from the National Multiple Sclerosis Society to conduct a novel study of outcome processing in individuals with MS.

26 Feb 2019

Neighborhood income, education associated with risk of disability progression in MS patients

Neighborhood income and education level is associated with risk of disability progression in patients with multiple sclerosis, suggests new research from the University of British Columbia.

23 Feb 2019

Innovative compound offers a new therapeutic approach to treat multiple sclerosis

Multiple sclerosis is an autoimmune disease that affects more than 2.3 million people worldwide. This debilitating condition periodically shutters communication between the brain and other parts of the body, resulting in symptoms that range from numbness and tingling in the arms and legs to blindness and paralysis.

22 Feb 2019

Intensive therapy during early stages of MS leads to better long-term outcomes

New findings by researchers at Cardiff University suggest that intensive therapy during the early stages of multiple sclerosis (MS) leads to better long-term outcomes for patients, despite it often being viewed as a riskier option than other first-line treatments.

21 Feb 2019

Researchers explain why T cells lose their protective ability in inflamed tissues

Regulatory T cells make sure that immune responses are not too strong and that inflammation is inhibited. This makes them highly interesting for therapies against inflammatory autoimmune diseases such as multiple sclerosis.

20 Feb 2019

Study finds new link between food allergies and multiple sclerosis

Like many other medical conditions, the mechanism of multiple sclerosis remains an enigma--a puzzle composed of complex genetic and environmental factors. A key piece to this puzzle is the immune system, which is also responsible for regulating many other physiological (and pathological) phenomena--including allergies.

19 Feb 2019

Researchers create new map of the brain's own immune system

A team of researchers under the direction of the Medical Center - University of Freiburg has created an entirely new map of the brain's own immune system in humans and mice.

19 Feb 2019

Study shows how neuroactive steroids inhibit activity of pro-inflammatory proteins

For the first time, scientists discovered how neuroactive steroids naturally found in the brain and bloodstream inhibit the activity of a specific kind of protein called Toll-like receptors, which have been known to play a role in inflammation in many organs, including the brain.

14 Feb 2019

Discovery of a 'master switch' within the immune system

Researchers Professor Graham Lord, from The University of Manchester and colleagues have found that a specific part of the immune system could have the tools that may help in the therapy of some major diseases such as diabetes, cancer, multiple sclerosis, Crohn’s disease and other autoimmune diseases.

14 Feb 2019

Study identifies protein regulator that induces Th17 cells to cause multiple sclerosis

Inflammatory and autoimmune diseases such as psoriasis, rheumatoid arthritis, and multiple sclerosis (MS) are a major healthcare burden worldwide and are life-altering conditions for afflicted patients.

14 Feb 2019

Keynote speakers announced for CBD Expo MIDWEST

CBD Expo Tour 2019, produced by MACE Media Group, one of the nation’s largest diversified media and information companies in the cannabis space and publisher of Terpenes and Testing Magazine, announced Celeste Miranda and Adam Dr. Adam Abodeely, MD, MBA, FACS, FASCRS will be the keynote speakers for CBD Expo MIDWEST in Indianapolis, Indiana to take place on March 15-16, 2019.

From CBD Expo Midwest 13 Feb 2019

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Fasting-mimicking diet changes gut microbiota to reduce IBD pathology in mice

New mathematical method to map cell regulatory networks

Daily cup of cocoa may reduce tiredness in multiple sclerosis

Sleep apnea may be related to higher accumulation of Alzheimer's biomarker in the brain

Research reveals how metabolites can be used to inhibit epigenetic mechanisms and treat MS

National Multiple Sclerosis Society awards grant for pilot study of social interaction in individuals with MS

Neighborhood income, education associated with risk of disability progression in MS patients

Innovative compound offers a new therapeutic approach to treat multiple sclerosis

Intensive therapy during early stages of MS leads to better long-term outcomes

Researchers explain why T cells lose their protective ability in inflamed tissues

Study finds new link between food allergies and multiple sclerosis

Researchers create new map of the brain's own immune system

Study shows how neuroactive steroids inhibit activity of pro-inflammatory proteins

Discovery of a 'master switch' within the immune system

Study identifies protein regulator that induces Th17 cells to cause multiple sclerosis

Keynote speakers announced for CBD Expo MIDWEST

Cell membrane complexes may be new target for drugs to kill cancer cells

Blood-clotting factor may cause Alzheimer's disease

Trump highlights health agenda with vow to lower ‘unfair’ drug prices

Fibrinogen results in cognitive decline in Alzheimer’s disease, finds study

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in